Veterans’ RightsAn independent resource for veterans
← All decisions
Denied

The Veteran's service-connected mantle cell lymphoma is rated as totally disabling, but the Board found that it may improve with treatment and thus not permanently disabling for DEA eligibility.

The deciding factor: Dr. M.B.'s medical records suggest the Veteran's stage IIA MCL could be considered cured if no relapse occurs within 10 years, making his disability not 'permanent in nature' as required by law.

Claimed conditions
malignant neoplasm - mantle cell lymphoma
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
None in this decision
Decision date
April 29, 2024
Citation
A24021760

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A24021760.

What this means for you

A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.